Startupticker.ch

Coople has rebuilt the technical foundation of its flexible staffing platform in less than a year, using AI in its own development work to speed delivery, and since August has onboarded all newly registered companies directly onto the new system. The rebuild comes as the Zurich company concentrates on its home market, having closed its UK operations on 1 January.

Biopôle SA just announced that Bewe has been awarded the Pre-Clinical Top-Up, marking the next phase of a long-standing relationship between our campus and the University of Fribourg spin-off, which is developing a neuroscience-based digital intervention for unhealthy food cravings.

MoonLake's lead candidate met clinical endpoints at week 16 of a Phase 3 psoriatic arthritis trial, while AC Immune has received FDA Fast Track designation for its Parkinson's immunotherapy, and Vandria has presented Phase 1 data indicating that its Alzheimer's candidate acts on the human brain.

03.09.2026 08:00 - 04.09.2026 11:30 Rue du Bugnon 25A, 1011 Lausanne, Switzerland The Society for Immunotherapy of Cancer (SITC) EU Immuno-Oncology Drug Development Summit at the Agora Cancer Research Center will facilitate understanding, open discussion, and exploration of best practices for modern immuno-oncology drug development while fostering international relationships between regulatory agencies, biotech, pharma, and academic investigators.

Nach einem Jahr intensiver Nutzung und Tests hat das Startup Zelsius seine Plattform zur Erfassung von Emissionen und der Berechnung einer CO₂-Bilanz für KMU aus zusätzlichen Branchen erweitert. Das Spin-off der Hochschule Luzern konnte die Anzahl Kunden verdoppeln und generiert mittlerweile einen sechsstelligen Umsatz – ein Grossteil davon stammt aus wiederkehrenden jährlichen Leistungen.

Aepsy erweitert mit der Akquisition des Schweizer Marktführers für betriebliche Gesundheitsförderung Kinastic sein Angebot um Prävention und betreut künftig über 150 Partnerunternehmen in der Schweiz. Das Kinastic-Team und die Plattform werden über die kommenden Monate integriert und gehen schrittweise in Aepsy auf.

Swiss Exchange-listed EvoNext Holdings confirms advanced discussions on a reverse merger with Ascend Sport Technology AG. Ascend is at the forefront of sport marketing and digital perimeter advertising. In response to recent media reports, EvoNext Holdings SA (SIX: EVE) confirms that it is in advanced discussions with Lucerne-based Ascend Sport Technology AG regarding a listing of Ascend on SIX Swiss Exchange by way of a reverse merger.

Most physical AI operates in static worlds. Self-driving cars steer around obstacles on smooth pavement, while humanoids and robotic arms move objects across fixed countertops or warehouse floors - leaving their surroundings completely undisturbed. An excavator does the exact opposite. It works by intentionally crashing into the environment, breaking apart varying soil with hidden rocks, and reshaping the earth with every pass of the bucket.

Spineart focuses on designing and developing solutions for spine surgery. One of its foundational technologies and a cornerstone of its cervical portfolio is BAGUERA C, a cervical disc prosthesis designed for disc replacement. Since its introduction, more than 80,000 units have been sold worldwide, with nearly two decades of international clinical experience.

Saved news Please login to see your bookmarks Get the newsletter Register for free to our services and get the newsletter Events Trainings Award deadlines Submit an event Abroad (9)Basel (2)Bern (5)Biel / Bienne (2)Chur (1)Fribourg / Freiburg (3)Genève (9)Hybrid (10)Lausanne (27)Lugano (3)Luzern (2)Neuchâtel (2)Other (20)Schlieren (10)St.Gallen (3)Webinar-Online (67)Winterthur (3)Yverdon (2)Zug (1)Zurich (40) Configure your own data insights with our huge database of swiss startups.